Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Exercise/Conversion of 14,475 ALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Altimmune, Inc. (ALT) | Exercise/Conversion | 14,475 | n/a |
| Aug 3, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 1,753 | $4.2K |
| Apr 1, 2026 | Altimmune, Inc. (ALT) | Purchase | 10,000 | $31.5K |
| Mar 9, 2026 | Altimmune, Inc. (ALT) | Purchase | 5,000 | $17.7K |
| Feb 27, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 259,000 | n/a |
| Nov 12, 2025 | Altimmune, Inc. (ALT) | Exercise/Conversion | 18,750 | n/a |
| Oct 3, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 166,800 | n/a |
| Mar 14, 2025 | Altimmune, Inc. (ALT) | Purchase | 10,000 | $52.0K |
| Nov 12, 2024 | Altimmune, Inc. (ALT) | Grant/Award | 225,000 | n/a |
| Nov 17, 2023 | ATOSSA THERAPEUTICS, INC. (ATOS) | Sale | 50,000 | $32.5K |